Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianling Liu

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center|November 25, 2022
Incidence and Prognosis Nomogram of Small Solitary Lung Cancer (≤2 cm) With Extra-Thoracic Metastasis at Initial Diagnosis:A Population-Based StudyAo'ran Hu, Zui Chen, Chaoyuan Liu, et al.
Clinical and Experimental Pharmacology & Physiology|June 9, 2026
Targeting S100A8/A9 Ameliorates Heart Failure with Preserved Ejection Fraction by Modulating TLR4/NF-κB-Mediated InflammationYansong Li, Qi Han, Xianling Liu, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|April 2, 2016
[Mechanisms for inhibitory effect of ALDH2 on doxorubicin-induced cytotoxicity in C2C12 myogenic cell line]Yawen Gao, Shicong Zhu, Yan Xu, et al.
Translational Cancer Research|February 4, 2022
Identification of plasma exosomes long non-coding RNA HAGLR and circulating tumor cells as potential prognosis biomarkers in non-small cell lung cancerLe Rao, Lihua Luo, Liufang Luo, et al.
Molecular Carcinogenesis|March 6, 2020
PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinomaYawen Gao, Lihua Luo, Yangchun Xie, et al.
Frontiers in Oncology|August 25, 2022
Case report: Major pathologic response induced by neoadjuvant treatment using BRAF and MEK inhibitors in a patient with stage IIIA lung adenocarcinoma harboring BRAF V600E-mutationChaoyuan Liu, Min Lu, Yang Yang, et al.
Sleep|July 31, 2009
GABAergic antagonism of the central nucleus of the amygdala attenuates reductions in rapid eye movement sleep after inescapable footshock stressXianling Liu, Linghui Yang, Laurie L Wellman, et al.
Experimental and Therapeutic Medicine|March 14, 2025
Association of cardiovascular disease and CIRS‑G and ACE‑27 comorbidity indices with pathological complete response of non‑small cell lung cancer to neoadjuvant chemoimmunotherapyXingsheng Hu, Ping Zhong, Chaoyuan Liu, et al.
Journal of Medical Internet Research|September 28, 2018
Using Artificial Intelligence (Watson for Oncology) for Treatment Recommendations Amongst Chinese Patients with Lung Cancer: Feasibility StudyChaoyuan Liu, Xianling Liu, Fang Wu, et al.
Translational Cancer Research|December 22, 2023
Development and validation of a nomogram for predicting the overall survival in non-small cell lung cancer patients with liver metastasisTian Xu, Xianling Liu, Chaoyuan Liu, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
Cancer Control : Journal of the Moffitt Cancer Center|November 25, 2022
Incidence and Prognosis Nomogram of Small Solitary Lung Cancer (≤2 cm) With Extra-Thoracic Metastasis at Initial Diagnosis:A Population-Based StudyAo'ran Hu, Zui Chen, Chaoyuan Liu, et al.
Clinical and Experimental Pharmacology & Physiology|June 9, 2026
Targeting S100A8/A9 Ameliorates Heart Failure with Preserved Ejection Fraction by Modulating TLR4/NF-κB-Mediated InflammationYansong Li, Qi Han, Xianling Liu, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|April 2, 2016
[Mechanisms for inhibitory effect of ALDH2 on doxorubicin-induced cytotoxicity in C2C12 myogenic cell line]Yawen Gao, Shicong Zhu, Yan Xu, et al.
Translational Cancer Research|February 4, 2022
Identification of plasma exosomes long non-coding RNA HAGLR and circulating tumor cells as potential prognosis biomarkers in non-small cell lung cancerLe Rao, Lihua Luo, Liufang Luo, et al.
Molecular Carcinogenesis|March 6, 2020
PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinomaYawen Gao, Lihua Luo, Yangchun Xie, et al.
Frontiers in Oncology|August 25, 2022
Case report: Major pathologic response induced by neoadjuvant treatment using BRAF and MEK inhibitors in a patient with stage IIIA lung adenocarcinoma harboring BRAF V600E-mutationChaoyuan Liu, Min Lu, Yang Yang, et al.
Sleep|July 31, 2009
GABAergic antagonism of the central nucleus of the amygdala attenuates reductions in rapid eye movement sleep after inescapable footshock stressXianling Liu, Linghui Yang, Laurie L Wellman, et al.
Experimental and Therapeutic Medicine|March 14, 2025
Association of cardiovascular disease and CIRS‑G and ACE‑27 comorbidity indices with pathological complete response of non‑small cell lung cancer to neoadjuvant chemoimmunotherapyXingsheng Hu, Ping Zhong, Chaoyuan Liu, et al.
Journal of Medical Internet Research|September 28, 2018
Using Artificial Intelligence (Watson for Oncology) for Treatment Recommendations Amongst Chinese Patients with Lung Cancer: Feasibility StudyChaoyuan Liu, Xianling Liu, Fang Wu, et al.
Translational Cancer Research|December 22, 2023
Development and validation of a nomogram for predicting the overall survival in non-small cell lung cancer patients with liver metastasisTian Xu, Xianling Liu, Chaoyuan Liu, et al.
Pageof 12